Pharma Investments, Ventures & Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Investments, Ventures & Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Adverse Drug Reactions
Studies from N. Morrison and co-researchers yield new data on adverse drug reactions
May 18th, 2008
A report, 'Comparisons of side effects using air and carbon dioxide foam for endovenous chemical ablation,' is newly published data in Journal of Vascular Surgery. "This clinical study evaluated prospectively adverse events immediately following ultrasound-guided foam sclerotherapy (UGFS) for the treatment of lower extremity venous valvular insufficiency. Incidence of side effects associated with carbon dioxide (CO(2)) foam was compared with a historical control using air-based foam," scientists in the United States report. "The literature on the subject was reviewed. Vital signs were monitored during and immediately after UGFS, and adverse events were recorded...
Source: Pharma Investments, Ventures & Law Weekly (2008-05-18)
|
